NASDAQ
No price data available for this timeframe.
Catalyst Pharmaceuticals, Inc. (CPRX) has a free cash flow growth of 32.77% as of Friday, May 29, 2026. This represents a 1134.27% increase compared to its 12-month average of -3.17%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.